tbuckley/cabot-search huggingface dataset:
Venetoclax (VEN) Plus Intensive Chemotherapy (IC) with FLAG-IDA in Patients (Pts) with Newly Diagnosed (ND) and Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Authors: Yasmin Abaza, Talha Khan, Shira Dinner, Olga Frankfurt, Jessica K. Altman
Journal: Blood (2022)
Good Prognosis of Adult Hemophagocytic Lymphohistiocytosis (HLH) Associated with the <i>HAVCR2</i> germline Mutation
Authors: Pitchayut Boonyabaramee, Chantana Polprasert, Sunisa Kongkiatkamon, Sirorat Kobbuaklee, Rung Settapiboon, Saranya Pongudom, Saruta Faknuam, Ponlapat Rojnuckarin
Journal: Blood (2022)
Idiopathic Multicentric Castleman Disease Interactive Disease Awareness and Educational Tool for Pathologists
Authors: Elena Sabattini, Jadee Neff, Daisy Alapat, Thomas Tousseyn, Grzegorz Rymkiewicz, Henrique Moura de Paula, Kateřina Kamarádová, Santiago Montes Moreno, Stephen Lade
Journal: Blood (2022)
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions
Authors: Agrima Mian, Wei Wei, Rajshekhar Chakraborty, Jean C. Yi, Jaime M. Preussler, Brian T. Hill, Jan Cerny, Abhinav Deol, Theresa E. Hahn, Shahrukh K. Hashmi, Samantha Jaglowski, Heather S.L. Jim, Nandita Khera, Alison W. Loren, Joseph P. McGuirk, Bipin N. Savani, Patrick Stiff, Joseph P. Uberti, Victoria Whalen, John R. Wingard, Jana Reynolds, Shernan G Holtan, William A. Wood, K. Scott Baker, Karen L. Syrjala, Betty K. Hamilton, Navneet S. Majhail
Journal: Blood (2022)
Health-Related Quality of Life of CML Patients Under 2nd or 3rd Line Bosutinib Is Not Impaired Significantly By Gastrointestinal Toxicity (GI Tox) but Influenced By Sex - Results from a Subanalysis of the Bosutinib Dose Optimization (BODO) Study (CML-VII) Trial of the German CML Study Group
Authors: Susanne Isfort, Dominik Wolf, Lino L. Teichmann, Martina Crysandt, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Alexander Kiani, Joachim R Göthert, Thomas Illmer, Philippe Schafhausen, Mareille Warnken-Uhlich, Uta Wolber, Denise Kohn, Kirsi Manz, Markus Pfirrmann, Tim H.H. Brummendorf
Journal: Blood (2022)
Phase I Open-Label Single-Arm Study of BCMA/CD19 Dual-Targeting FasTCAR-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma
Authors: Juan Du, Weijun Fu, Jing Lu, Wanting Qiang, Haiyan He, Jin Liu, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wei Cao
Journal: Blood (2022)
Non-Invasive Optical Characterization of Tissue Hemodynamics in Sickle Cell Patients Undergoing Treatment with Isoquercetin
Authors: Elise M. Berning, Timothy Quang, Mai Hill, Brenda Merriweather, Maria A. Lizarralde-Iragorri, Bindu Parachalil Gopalan, Arun S. Shet, Bruce J. Tromberg
Journal: Blood (2022)
An Observational Prospective Study of Dasatinib 50mg Daily As Frontline Therapy in Newly Diagnosed Chronic Myeloid Leukemia Patients in Chronic Phase
Authors: Reema Singh, Rohan Halder, Jyotsna Kapoor, Megha Verma, Pallavi Mehta, Narendra Agrawal, Rayaz Ahmed, Dinesh Bhurani
Journal: Blood (2022)
Mutation Spectrum of FLT3 and Significance of Non-Canonical FLT3 Mutations in Hematological Malignancies
Authors: Shuai-Shuai Ge, Xiangdong Shen, Tianmei Wu, Jiahui Du, Haiping Dai, Qiaocheng Qiu, Songbai Liu, Depei Wu, Shengli Xue
Journal: Blood (2022)
Phase II Study of a JAK1/2 Inhibitor Ruxolitinib for Systemic Chronic Active Epstein-Barr Virus Disease: An Investigator-Initiated Trial
Authors: Yu Uemura, Masahide Yamamoto, Masataka Ishimura, Hirokazu Kanegane, Akihisa Sawada, Akihiro Hirakawa, Ken-Ichi Imadome, Mayumi Yoshimori, Masashi Nagata, Norio Shimizu, Ryuji Koike, Ayako Arai
Journal: Blood (2022)
Predictors of Response to Venetoclax Plus Hypomethylating Agent Therapy and Survival in Blast-Phase Myeloproliferative Neoplasm
Authors: Naseema Gangat, Rimal Ilyas, Kristen McCullough, Kebede H. Begna, Aref Al-Kali, Mrinal M.M. Patnaik, Mark R. Litzow, William J. Hogan, Abhishek A. Mangaonkar, Hassan B. Alkhateeb, Mithun V. Shah, Michelle A Elliott, James M. Foran, Talha Badar, Jeanne M. Palmer, Curtis A. Hanson, Animesh Pardanani, Ayalew Tefferi
Journal: Blood (2022)
<i>In silico</i> Evaluation of BTK Inhibitors Mechanisms That Could Induce Atrial Fibrillation and Hypertension in the Treatment of Chronic Lymphocytic Leukemia
Authors: Raul Cordoba, Dolors Colomer, Antoni Bayés-Genís, Carolina Leiva Farre, Esther Álvarez, María Dolores López, Eduardo Zatarain
Journal: Blood (2022)
Treatment with Oral Azacitidine in Elderly Patients with Higher Risk Myelodysplastic Syndromes after Response to Subcutaneous Azacitidine
Authors: Valeria Santini, Cristina Amato, Barbara Caciagli, Angela Consagra, Luca Rigodanza, Sven de Pourcq, Margherita Cassari, Elena Tofacchi, Giorgio Mattiuz, Marco Gabriele Gabriele Raddi, Alessandro Sanna
Journal: Blood (2022)
Familial Predisposition to B-Cell Precursor Acute Lymphoblastic Leukemia Mediated By <i>PAX5</i> Germline Variants
Authors: Franziska Auer, Adela Escuerdo, Ulrike Anne Friedrich, Polina Stepensky, Arndt Borkhardt, Sarah Elitzur, Masatoshi Takagi, Julia Hauer
Journal: Blood (2022)
Pelabresib (CPI-0610) Combined with Ruxolitinib for JAK Inhibitor Treatment-Naïve Patients with Myelofibrosis: Durability of Response and Safety Beyond Week 24
Authors: John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Vikas Gupta, Francesca Palandri, Timothy Devos, Raajit K Rampal, Moshe Talpaz, Alessandro Vannucchi, Andrew Kuykendall, Jean-Jacques Kiladjian, Srdan Verstovsek, Ruben Mesa, Gozde Colak, Qing Li, Sandra Klein, Claire Harrison
Journal: Blood (2022)
Esplorhem: Evaluation of Spanish Experience of Using Florio® Haemo Digital Medical Device for Treatment Monitoring in Hemophilia Patients. a Preliminary Report
Authors: Francisco José López-Jaime, Olga Benitez, Nuria Caballero, Rubén Berrueco, Eva Álvarez, Ihosvany Fernandez-Bello, Miguel Blanquer Blanquer, Adrián Montaño
Journal: Blood (2022)
Nutritional and Cytogenetic Assessment Predicts Favorable Response to Azacitidine Monotherapy for Myelodysplastic Syndromes
Authors: Haruya Okamoto, Yu Inoue, Akihiro Miyashita, Yuka Kawaji-Kanayama, Shotaro Chinen, Takahiro Fujino, Taku Tsukamoto, Yuji Shimura, Shinsuke Mizutani, Hiroto Kaneko, Saeko Kuwahara, Shin-ichi Fuchida, Daichi Nishiyama, Koichi Hirakawa, Junya Kuroda
Journal: Blood (2022)
Molecular Diagnostics for <i>TP53</i> Is Recommended in B-Cell Lymphomas
Authors: Lorraine M. De Haan, Ruben A.L. De Groen, Fleur de Groot, Troy Noordenbos, Tom van Wezel, Ronald van Eijk, Dina Ruano, Arjan Diepstra, Lianne Koens, Aniko Sijs-Szabo, Hendrik Veelken, Arjen Cleven, Patty M. Jansen, Joost S.P. Vermaat
Journal: Blood (2022)
Combined Treatment with Ibrutinib and Anti-CD38 Monoclonal Antibody Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia with TP53 Aberrations: Results of the Filo Phase II Study IDA53
Authors: Therese Aurran-Schleinitz, Cécile Tomowiak, Damien Roos-Weil, Emmanuelle Ferrant, Béatrice Mahé, Lysiane Molina, Loic Ysebaert, Luc Mathieu Fornecker, Anne-Sophie Michallet, Vincent Levy, Romain Guieze, Alain Delmer
Journal: Blood (2022)
Characterization of Terminal Erythroid Differentiation (TED) and Its Prognosis Impact Inpatients with Myelodysplastic Syndrome (MDS)
Authors: Marc Bosch Schips, Julia Montoro, Félix López Cadenas, Alba Mesa, Víctor Navarro Garcés, Ana Pérez, Laura Gallur, Silvia Saumell, Mayda Navarrete, Margarita Ortega, Bárbara Tazón, Antonieta Molero, Olga Salamero, Sandra Novoa Jáuregui, Sofia Laura Muzio, Francesc Bosch, David Valcárcel
Journal: Blood (2022)
Weight Change Trends and Impact of Body Mass Index (BMI) on Outcomes in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma, a Retrospective Analysis from the Lymphoma Innovations Orien Network (LION) Consortium
Authors: Yazeed Sawalha, Chenxi Du, Jeffrey M. Switchenko, Melissa Kives, Michelle L. Churchman, Deborah M. Stephens, Javier Pinilla Ibarz, Andrew Matthew Evens, Kami J. Maddocks, Brian K. Link, Jonathon B. Cohen, Craig A. Portell
Journal: Blood (2022)
Refining Clinical Risk Stratification for Estimating the Risk of Ischemic Stroke in Non-Atrial Fibrillation Patients with a Novel Risk Stratification Tool, CHA₂DS₂-Vasc + Score
Authors: Abinesh Sekar, Maya Gogtay, Harinivaas Shanmugavel Geetha, Ankushi Sanghvi, Yuvaraj Singh, Prachi Laxman Balani, Deep Shah, Susan V George
Journal: Blood (2022)
Combined Genetic Ablation of CD54 and CD58 in CAR Engineered Cytotoxic Lymphocytes Effectively Averts Allogeneic Immune Cell Rejection
Authors: Quirin Hammer, Karlo Perica, Rina M Mbofung, Hanna van Ooijen, Erika Varady, Mark Jelcic, Yijia Pan, Pouria Momayyezi, Brian Groff, Ramzey Abujarour, Silje Zandstra Krokeide, Tom Lee, Alan M Williams, Jode P Goodridge, Bahram Valamehr, Bjorn Onfelt, Michel Sadelain, Karl-Johan Malmberg
Journal: Blood (2022)
FISH Analysis of <i>CDKN2A/B</i> Deletion in Chronic Lymphocytic Leukemia
Authors: Samantha M Teierle, Ying Huang, Adam S Kittai, Seema A. Bhat, Michael R. Grever, Kerry A. Rogers, Weiqiang Zhao, Daniel Jones, John C. Byrd, Matthew R Avenarius, Nyla A. Heerema, Jennifer A. Woyach, Cecelia Miller
Journal: Blood (2022)
A Phase I Clinical Trial of Point-of-Care Manufactured Fresh Anti-CD19/20/22 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, B Prolymphocytic Leukemia)
Authors: Sumithira Vasu, Lapo Alinari, Nicole Szuminski, Dina Schneider, Nathan Denlinger, Wing Keung Chan, Khalid Parris, Nidhi Sharma, Hillary Bradbury, Beth Daneault, Lynn O'Donnell, Boro Dropulic, Marcos J.G. de Lima
Journal: Blood (2022)
Predictors of Adverse Clinical Outcome in Diffuse Large B-Cell Lymphoma Richter Transformation of CLL/SLL: A Consortium of Richter Transformation Investigators (CORTI) Multicenter Study across 8 US, UK, and Australian Academic Centers
Authors: Emily Symes, Zhihong Hu, Stephen K. Walker, Vishakha Sovani, Nicolas Lopez-Hisijos, Barina Aqil, Mir Alikhan, Claudiu V. Cotta, Sean Harrop, Angela Lager, Beenu Thakral, Peter A. Riedell, Carrie Fitzpatrick, Michael J. Thirman, Anand Ashwin Patel, Caner Saygin, Sandra L. Ondrejka, Michael R. Bishop, Amir Behdad, Sandeep Gurbuxani, Daniel A. Arber, M. James You, Richard A. Larson, Sonali M. Smith, Yan Amber Hodgson, Justin Kline, Matthew Ku, Girish Venkataraman
Journal: Blood (2022)
Allogeneic Donor-Derived Myeloid Antigen Directed CAR-T Cells - for Relapsed/Refractory Acute Myeloid Leukemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: Report of Three Cases
Authors: Larisa Shelikhova, Arina Rakhteenko, Olga Molostova, Elena Kurnikova, V. Ukrainskaya, Yakov Muzalevsky, Dmitry Pershin, Alexander Popov, Elena Kulakovskaya, Dina Baidildina, Alexey Stepanov, Elena Osipova, Galina Novichkova, Alexey Maschan, Michael Maschan
Journal: Blood (2022)
PD-1 Inhibitors Can be the First-Line Therapy for Myelodysplastic Syndrome (MDS) --Study on the Bone Marrow Immune Microenvironment of MDS By Multispectral Imaging of Multiplex Immunofluorescence
Authors: Minghua Hong, Ying Xie, Jing Zhao, Ting Lu, Jie Sun, He Huang
Journal: Blood (2022)
CD123 Directed IgM Antibody-based T-cell Engager, IGM-2537, Demonstrates Potent in vitro and in vivo Activity with Minimal Cytokine Release
Authors: Liqin Liu, Gene Li, Ling Wang, Poonam Yakkundi, Paul R. Hinton, Deepal Pandya, Manal Amoury, Keerthana Sekar, Chian Liu, Rodnie Rosete, Nardeen Hanna, Maya F. Kotturi, Liz Bogaert, Jiyoung Hong, Christina Tsai, Bruce A. Keyt, Angus M. Sinclair
Journal: Blood (2022)
Luspatercept in Combination with Recombinant-Erythropoietin in MDS RS Patients: Stimulating Early and Late Erythropoiesis
Authors: Francesco Versino, Marta Bortolotti, Beatrice Ferrari, Lorenzo Rizzo, Federico Mazzon, Marta Riva, Paola Bianchi, Wilma Barcellini, Bruno Fattizzo
Journal: Blood (2022)
Homoharringtonine Synergizes Strongly with Venetoclax Against the Early T-Cell Progenitor Acute Lymphoblastic Leukemia：from Bench to Bed
Authors: Shanshan Suo, Shu SUN, Jiejing Qian, Dandan Zhao, Wenjuan Yu, Yinjun Lou, Honghu Zhu, Hongyan Tong, Min Yang, Xin Huang, Shuqi Zhao, Junjing Qiao, Chen Liang, Fenglin Li, Huafeng Wang, Yi Zhang, Le Xuan Truong Nguyen, Dinh Hoa Hoang, Fang Chen, Jie Sun, Ivan Rodriguez, Lucy Ghoda, Ling Li, Bin Zhang, Guido Marcucci, Jie Jin
Journal: Blood (2022)
Real-World Outcomes of Emicizumab in Hemophilia A with or without FVIII Inhibitors from the Canadian Hemophilia Bleeding Disorder Registry
Authors: Man-Chiu Poon, Adrienne Lee, Federico Germini, Arun Keepanasseril, Quazi Ibrahim, Francis Nissen, Katya Moreno, Michelle Santos, Emma Iserman, Davide Matino, Alfonso Iorio
Journal: Blood (2022)
Reconstructing the Genomic History of Multiple Myeloma Precursor Disease: Novel Insights and Clinical Applicability
Authors: Jean-Baptiste Alberge, Ankit K. Dutta, Elizabeth D. Lightbody, Andrea Poletti, Andrew Dunford, Oliver Priebe, Julian M. Hess, Cody J. Boehner, Romanos Sklavenitis-Pistofidis, Nang Kham Su, Erica Horowitz, Hadley Barr, Jenna B. Beckwith, Laura Hevenor, Katherine Towle, Jacqueline Perry, Esther Rheinbay, Chip Stewart, Gad Getz, Irene Ghobrial
Journal: Blood (2022)
Updated Results of CPX-351 in Combination with Gemtuzumab Ozogamicin (GO) in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) and Post-Hypomethylating Agent (Post-HMA) Failure High-Risk Myelodysplastic Syndrome (HR-MDS)
Authors: Jayastu Senapati, Emmanuel Huante Almanza, Tapan M. Kadia, Guillermo Montalban-Bravo, Stefan Faderl, Koji Sasaki, Nicholas Short, Naval Daver, Courtney D. DiNardo, Lucia Masarova, Alessandra Ferrajoli, Elias Jabbour, Gautam Borthakur, Hind Al Azzawi, Marina Konopleva, Guillermo Garcia-Manero, Michael Andreeff, Hagop Kantarjian, Farhad Ravandi, Yesid Alvarado
Journal: Blood (2022)
Transition from Initial Therapy to Hematopoietic Cell Transplantation for Non-Favorable Risk Acute Leukemia and MDS Patients in the Era of Haploidentical Donor Availability: Assessment of Efficacy, Barriers and Racial Disparities in 269 Consecutive Patients Treated in an Integrated Leukemia/HCT Program
Authors: Asad Bashey, Xu Zhang, Melhem Solh, H. Kent Holland, Lawrence E. Morris, Lizamarie Bachier-Rodriguez, Scott R. Solomon
Journal: Blood (2022)
Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival
Authors: Ruben A.L. De Groen, Fleur A De Groot, Lorraine M. De Haan, Tom van Wezel, Troy Noordenbos, Stefan Boehringer, Ronald Van Eijk, Richard Raghoo, Dina Ruano, Aniko Sijs-Szabo, Liane te Boome, Valeska Terpstra, Henriette Levenga, Aline Nicolae, Ward Posthuma, Isabelle Focke-Snieders, Lizan Hardi, Wietske den Hartog, Lara H. Böhmer, Anke Van Den Berg, Pim Mutseaers, Marjolein W.M. Van Der Poel, Myrurgia Abdul Hamid, F.J. Sherida H. Woei-a-Jin, Ann Janssens, Thomas Tousseyn, Judith Bovée, Hendrik Veelken, Steven T Pals, Arjan Diepstra, Marcel Nijland, Marie José Kersten, Patty M. Jansen, Arjen Cleven, Joost S.P. Vermaat
Journal: Blood (2022)
"...Paying to be a Patient in the Hospital and the Parking Lot": Dyadic Perspectives on Multiple Myeloma-Related Healthcare Access Barriers
Authors: Gabriell Erisnor, Jiona Mills, Paul Mihas, Lauren Bates, Mykela Moore, Tanya M. Wildes, Leah Adams, Hyman B Muss, Shakira J. Grant
Journal: Blood (2022)
Outcome of Patients Undergoing Hematopoietic Cell Transplantation for TP53-Mutated Acute Leukemias and MDS: Effect of Conditioning and GvHD Prophylaxis Regimens Intensity
Authors: Amrita Desai, Karamjeet S. Sandhu, Paul B. Koller, Dongyun Yang, Brian J Ball, Sally Mokhtari, Amanda Blackmon, Salman Otoukesh, Shukaib Arslan, Idoroenyi Amanam, Amandeep Salhotra, Ahmed Aribi, Ibrahim Aldoss, Andrew S. Artz, Haris Ali, Anthony S. Stein, Guido Marcucci, Stephen J Forman, Ryotaro Nakamura, Michelle Afkhami, Monzr M. Al Malki
Journal: Blood (2022)
Comparison of Hidac Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Study
Authors: Man Wai Tang, Deborah van der Tuin, Mesire Aydin, Jarom Heijmans, Arjan A. van de Loosdrecht, Ellen Meijer, Caroline E. Rutten, Marielle Wondergem, Jeroen J.W.M. Janssen, Marjolein Donker, Mette D. Hazenberg, Sonja Zweegman, Bart J. Biemond, David C. de Leeuw, Erfan Nur
Journal: Blood (2022)
The DNA-Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease
Authors: Jonathan Visentin, Wei Jia, Jonathan C Poe, Hsuan Su, Sofian Christina, Rachel A. DiCioccio, Itaevia Curry-Chisolm, Fahmin Basher, Sonali Bracken, Vincent T Ho, Vanja Sisirak, Mitchell E. Horwitz, Nelson J. Chao, Stefanie Sarantopoulos
Journal: Blood (2022)
Pilot Inter-Laboratory Comparison Study of Optical Genome Mapping Analysis for Cytogenomic Characterization of Hematological Malignancies: A Spanish Multicentric Study
Authors: Anna Puiggros, Mar Mallo, Marta Salido, Ana Gómez-García, Adela Cisneros, Rocío García-Serra, Celia González-Gil, Gayane Avetisyan, María Rodríguez-Rivera, Alvaro Diaz-Gonzalez, Isabel Granada, Esperanza Such, Eulàlia Genescà, Rosa Collado, Manuel Ramírez-Orellana, Francesc Solé, Blanca Espinet
Journal: Blood (2022)
The RNA Binding Protein Musashi-2 (MSI2) Sustains the Growth and the Leukemogenic Potential of MLL-Rearranged Acute Lymphoblastic Leukemia, and It Is Involved in Glucocorticoid Resistance
Authors: Luigia Valsecchi, Simone Naso, Simona Procopio, Mario Mauri, Rocco Piazza, Titus Watrin, Sanil Bhatia, Valentina Pasquale, Elena Sacco, Chiara Palmi, Grazia Fazio, Luca Trentin, Silvia Bresolin, Andrea Biondi, Giovanni Cazzaniga, Michela Bardini
Journal: Blood (2022)
Momelotinib (MMB) Long-Term Safety: Pooled Data from Three Phase 3 Randomized-Controlled Trials (RCTs)
Authors: Srdan Verstovsek, Ruben Mesa, Vikas Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy, Stephen T Oh, Jean-Jacques Kiladjian, Alessandro M Vannucchi, Aaron T. Gerds, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire Harrison
Journal: Blood (2022)
The Protein Interactome of DNMT3A<i>,</i> and Altered Interactions Caused By Missense Mutations Associated with AML and/or the DNMT3A Overgrowth Syndrome
Authors: Yang Li, Ziheng Xu, Ryan B Day, Yiling Mi, Petra Erdmann-Gilmore, R. Reid Townsend, Timothy J Ley
Journal: Blood (2022)
DR-01, a Non-Fucosylated Anti-CD94 Antibody, Depletes Leukemic Cells in Ex Vivo and In Vivo Models of Large Granular Lymphocyte Leukemia
Authors: Kelly Shi, Cindy Tan, Lu Bai, Jennifer Richardson, Andy Deng, Matthias Will, Michael Brehm, Dale Greiner, Leonard Shultz, Antonella Teramo, Renato Zambello, David J Feith, Thomas P. Loughran, Nenad Tomasevic
Journal: Blood (2022)
Two Sides of the Same Transdifferentiated Coin: A Case Vignette and Review of the Literature Exploring the Relationship between B Cell Non-Hodgkin Lymphoma, Histiocytic Sarcoma and Interdigitating Dendritic Cell Sarcoma
Authors: Kriti Gera, Robert Patrick Seifert, Jamie B Harris, Aaron J Franke
Journal: Blood (2022)
Acalabrutinib Plus Rituximab with or without Lenalidomide in Patients with Follicular Lymphoma: A Multipart, Open-Label, Phase 1b Trial
Authors: Paolo Strati, Beth Christian, Peter Martin, Becky Champion, Morton Coleman, Richy Agajanian, Sonali M. Smith, Parameswaran Venugopal, Izidore S. Lossos, Robert Kridel, Roser Calvo, Kara Higgins, Deborah M. Stephens
Journal: Blood (2022)
Online Platform for SAMD9 and SAMD9L Variant Annotation and Phenotype Correlation
Authors: Masanori Yoshida, Felicia Andresen, Hermann Yang, Sara Lewis, Miriam Erlacher, Dirk Lebrecht, Akiko Shimamura, Charlotte M. Niemeyer, Sushree S Sahoo, Marcin W Wlodarski
Journal: Blood (2022)
Evaluation of Bleeding and Thrombocytopenia in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A Systematic Review
Authors: Jiayu Yang, Nora Choi, Kristjan Paulson, David Sanford, Lee Mozessohn, Donald S. Houston, Emily Rimmer, Sylvain Lother, Asher Mendelson, Allan Garland, Rena Buckstein, Annette E. Hay, Ryan Zarychanski, Brett L. Houston
Journal: Blood (2022)
CD72 Is a Pan-Tumor Antigen Associated with Childhood Acute Leukemia
Authors: Barbara Buldini, Giovanni Faggin, Elena Porcù, Pamela Scarparo, Katia Polato, Claudia Tregnago, Elena Varotto, Paolo Rizzardi, Carmelo Rizzari, Franco Locatelli, Alessandra Biffi, Martina Pigazzi
Journal: Blood (2022)
Initial Treatment Response Is Prognostic and Predictive of Relapse Patterns: Outcomes of &amp;gt;500 Patients Treated for Primary CNS Lymphoma
Authors: Kathryn R. Tringale, Joachim Yahalom, Michael Scordo, Gustav Y Cederquist, Behroze Vachha, Lauren Schaff, Carla Hajj, Harper Hubbeling, Zhigang Zhang, Charlie White, Christian Grommes, Brandon S. Imber
Journal: Blood (2022)
Intracellular Calcium Localization Mediates the Activity of Venetoclax in Targeting Acute Myeloid Leukemia Stem Cells
Authors: Anagha Inguva, Krysta L. Engel, Hunter Tolison, Mark J Althoff, Shanshan Pei, Maria L. Amaya, Anna Krug, Mohammad Minhajuddin, Courtney L Jones, Austin E. Gillen, Monica Ransom, Sarah Staggs, Daniel A. Pollyea, Clayton Smith, Brett M. Stevens, Craig T. Jordan
Journal: Blood (2022)
A Single Center Analysis of Hematopoietic Recovery in Patients Undergoing Allogeneic BMT with Suboptimal CD34+ Doses
Authors: John X Wei, Nina Samuel, Richard Elkind, Carlo Palesi, Aditi Shastri, R. Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Kira Gritsman, Amit Verma, Mendel Goldfinger, Dennis Cooper, Nishi Shah
Journal: Blood (2022)
Single-Cell Multi-Omics Analysis Reveals Hematopoiesis of Aberrant Mast Cells in Systemic Mastocytosis
Authors: Chenyan Wu, Daryl Boey, Jiezhen Mo, Sofia Papavasileiou, Johanna Ungerstedt, Miao Xu, Gunnar Nilsson, Joakim S. Dahlin
Journal: Blood (2022)
Gut Microbiome, Metabolome and Immune Changes in Myelodysplastic Syndromes
Authors: Ekaterina Balaian, Nikolai Karcher, Katja Sockel, Uta Oelschlägel, Alexander Funk, Manja Wobus, Maria Uhlig, Matthias W. Groß, Sebastian Zeissig, Martin Bornhaeuser, Triantafyllos Chavakis, Georg Zeller
Journal: Blood (2022)
Carfilzomib Use Among Patients with Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: Characteristics and Outcomes By Regimen from a Prospective, Real-World Study
Authors: Hang Quach, Sung-Soo Yoon, Kihyun Kim, Ji Hyun Lee, Chandramouli Nagarajan, Phoebe Joy Ho, Michael S.Y. Low, Wei-Han Huang, Raymond Wong, Nina Liao, ChingFeng Lin, Matthew Britland, Julia Li, Stella Chai, Jin Seok Kim
Journal: Blood (2022)
Lactate Utilization Provides a Metabolic Escape to Resist the Antileukemic Activity of BET Inhibition in Acute Myeloid Leukemia
Authors: Andrew J. Monteith, Haley E. Ramsey, Dalton Greenwood, Maria P. Arrate, Londa Fuller, Agnieszka E. Gorska, Alexander J. Silver, Donovan J. Brown, Sarah D. Olmstead, Jackson Watke, Matthew J. Stubbs, Jeffrey C. Rathmell, Michael R. Savona
Journal: Blood (2022)
Outcome of Advanced Stage Diffuse Large B-Cell Lymphoma; Experience from Saudi Arabia
Authors: Ahmed Alaskar, Naila Shaheen, Farhan Khalid, Mohsen Alzahrani, Giamal Edin Gmati, Bader Alahmari, Hind Salama, Bayan Albadah, May Anne Mendoza, Maryam Almotairi, Rania Jaha, Ayman Alhejazi
Journal: Blood (2022)
Expression Profiles of Human Endogenous Retrovirus in Chronic Myeloid Leukemia at Diagnosis and after TKI Therapy
Authors: Maria Monne, Sara Piras, Giovanna Piras, Roberto Cusano, Antonella Uras, Marco Murineddu, Alessandro Murgia, Angelo D. Palmas, Enzo Tramontano, Nicole Grandi
Journal: Blood (2022)
Pttapp: An Application Developed By the Spanish Society of Hematology and Hemotherapy to Show Practical Recommendations on the Management of Immune TTP
Authors: Maria Eva Mingot-Castellano, Rosa Goterris, Moraima Jiménez, Valle Recasens, Saioa Zalba, Marta Fernandez-Docampo, Ana Kerguelen Fuentes, Jose Garcia-Arroba, Inés Gómez-Seguí, David Valcárcel, Cristina Pascual Izquierdo
Journal: Blood (2022)